Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Faculty Presentations)Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Faculty Presentations)
Aditya Bardia, MD, MPH
Director, Breast Cancer Research Program Associate Professor Harvard Medical School Attending Physician Massachusetts General Hospital Boston, Massachusetts Erika Hamilton, MD |